Cell line · CVCL_0460
NCM460
Spontaneously immortalized cell line, Homo sapiens. 53 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. NCM460. Cell lines, record CVCL_0460. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0460
On this page
Cell line
As Cellosaurus gives it.
- Name
- NCM460
- Accession
- CVCL_0460
- RRID
- RRID:CVCL_0460
- Synonyms
- NCM-460
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 68Y
- Category
- Spontaneously immortalized cell line
- Derived from
- Colon, mucosa (in situ)
- Cell type
- Epithelial cell of colon
- Entry created
- 2012-04-04
- Entry updated
- 2025-04-10
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers53
2 more articles give this line's RRID in its Methods without naming the line nearby, so they are not listed.
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Integrative genomics and experimental validation identify a mechanosensitive gene signature associated with colorectal cancer liver metastasis. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Identification of Immuno-Diagnostic and Therapeutic Markers in Tumors and Inflammatory Diseases Based on Single-Cell and Machine Learning Methods. | Hum Mutat | 2026 | Its Methods give the RRID and name the line | PubMed | |
| MZF1 Inhibits TGFβ-1/SMAD Signaling by Transcriptionally Activating SnoN to Augment Tumorigenic Potential in Colon Cancer. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Bletilla striata polysaccharide as a form-dictating carrier enhances the local efficacy of low-dose 5-aminosalicylic acid for intestinal mucosal healing. | Biomater Biosyst | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Lactobacillus salivarius potentiates gastrointestinal cancer immunotherapy through its metabolite chenodeoxycholic acid. | Cell Rep Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A Novel tRNA Half mt-5'-tiRNA-Tyr Promotes Colorectal Cancer Proliferation via Inducing HARS2 Succinylation. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Synthesis and biological evaluation of oridonin derivatives as antiproliferative agents against colorectal cancer. | RSC Med Chem | 2026 | Its Methods give the RRID and name the line | PubMed | |
| An epithelial-mesenchymal transition-related gene signature predicts prognosis, immune infiltration, and drug sensitivity in colorectal cancer. | Cancer Drug Resist | 2026 | Its Methods give the RRID and name the line | PubMed | |
| GPR39 Suppresses Ferroptosis via the Nrf2/SLC7A11 Axis and Reduces the Sensitivity of Colorectal Cancer to Anti-PD-1 Immunotherapy. | Can J Gastroenterol Hepatol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Gene expression adaptation of metastases to their host tissue. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 53
See all 53 papersRelatives3
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | HyCyte NCM460 KO-hMAP3K20 | CVCL_F4DX | Cell lines | |
| Derived from it | HyCyte NCM460 stable cell line for hGSDMC overexpression | CVCL_F4SP | Cell lines | |
| Derived from it | NCM460D | CVCL_IS47 | Cell lines |
Cell banks1
| Cell bank | Catalog number | Status |
|---|---|---|
| CLS | 305430 |
Source CLS
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0460
GET https://conductscience.org/api/cell-lines/v1/CVCL_0460/papers?page=2